Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 5/20 | 0.57 |
| ▸ | F10 | P00742 | 10/20 | 0.50 |
| ▸ | CALML3 | P27482 | 2/20 | 0.50 |
| ▸ | MAOB | P27338 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | SDHA | P31040 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13054876 | 0.88 | MAOA (0.52) | MAOAF10CALML3MAOBLMNA | |
| SCHEMBL3806686 | 0.85 | MAOA (0.51) | MAOAF10CALML3MAOBLMNA | |
| SCHEMBL3747929 | 0.85 | MAOA (0.51) | MAOAF10CALML3MAOB | |
| SCHEMBL3753109 | 0.85 | MAOA (0.51) | MAOAF10CALML3MAOBLMNA | |
| SCHEMBL14024092 | 0.82 | MAOA (0.56) | MAOAF10CALML3MAOBLMNA | |
| SCHEMBL1556065 | 0.79 | MAOA (0.63) | MAOAF10CALML3MAOBLMNA | |
| SCHEMBL3753131 | 0.78 | MAOA (0.59) | MAOAF10CALML3MAOBLMNA | |
| SCHEMBL3764737 | 0.78 | MAOA (0.59) | MAOAF10CALML3MAOBLMNA | |
| SCHEMBL3760120 | 0.78 | CALML3 (0.48) | MAOAF10CALML3MAOB | |
| SCHEMBL3760059 | 0.78 | MAOA (0.47) | MAOAF10CALML3MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100298384-A1 | NOVEL OXAZOLIDINONE COMPOUNDS AS ANTIINFECTIVE AGENTS | DR. REDDY'S LABORATORIES LTD. (IN) | 2010-11-25 | — | — | US | disclosed |
| WO-2008143649-A2 | NOVEL OXAZOLIDINONE COMPOUNDS AS ANTIINFECTIVE AGENTS | DR. REDDY'S LABORATORIES LIMITED (IN) | 2008-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298384-A1 | NOVEL OXAZOLIDINONE COMPOUNDS AS ANTIINFECTIVE AGENTS | OXA1L, MIF, VIP | MAOA 3034/4885F10 4714/4885CALML3 4408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.